12 Feb 2013 - Asuragen Presents Data on Next Generation Sequencing of FFPE Tumor Samples at Molecular Medicine Tri-Conference 2013

Asuragen Inc., a leading molecular diagnostic company, today presented data on SuraSeq?, its proprietary enrichment method for targeted next-generation...

01 Feb 2013 - Research and Markets: Global Array Instruments Market 2012-2016 with Bio-Rad Laboratories Inc., Siemens and Illumina Inc. Dominating

Research and Markets (http://www.researchandmarkets.com/research/dcq2rh/global_array) has announced the addition of the "Global Array Instruments Market...

15 Ene 2013 - Illumina Announces Recipients of Agricultural Greater Good Initiative Grants

Illumina, Inc. (NASDAQ: ILMN) today announced two new grant recipients of its Agricultural Greater Good Initiative at the 21st International Plant and...

15 Ene 2013 - Illumina to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Monday, January 28, 2013

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2012 following the close of market on Monday,...

09 Ene 2013 - Research and Markets: The Global Microfluidic Devices Market in the Healthcare Industry to Grow At A CAGR Of 26.7 Percent over the Period 2011-2015

Research and Markets (http://www.researchandmarkets.com/research/fnv97g/global) has announced the addition of the "Global Microfluidic Devices Market in...

09 Ene 2013 - PerkinElmer and Verinata Health Announce Collaboration to Expand Access to Non-Invasive Prenatal Test for Down Syndrome and Other Chromosomal Abnormalities

PerkinElmer, Inc. (NYSE: PKI) and Verinata Health, Inc., today announced a strategic agreement for expanding access to Verinata?s verifi® test, the most...

07 Ene 2013 - Illumina Strengthens Leadership Position in Reproductive Health with Agreement to Acquire Verinata Health, Inc.

Illumina, Inc. (NASDAQ:ILMN) today announced that it has signed a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive...

29 Nov 2012 - Illumina Names Dr. Robert S. Epstein to its Board of Directors

Illumina, Inc. (NASDAQ: ILMN) today announced that Dr. Robert S. Epstein, M.D., has joined the company?s Board of Directors. Dr. Epstein is an epidemiologist...

26 Nov 2012 - Illumina Announces New Ruling in its Patent Litigation Against Complete Genomics, Inc.

Illumina, Inc. (NASDAQ:ILMN) announced that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California granted...

19 Nov 2012 - LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.09

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.09, on November 18, 2012. The...

14 Nov 2012 - Illumina to Webcast Live Presentation at Piper Jaffray Health Care Conference

Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company?s presentation at the Piper Jaffray Healthcare Conference in New York, New...

Cotizaciones

 De Hoy

 De los Últimos Días

 Del Año